|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| G01N 33/68 |
| (11) | Patento numeris | 2310415 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09734929.4 |
| Europos patento paraiškos padavimo data | 2009-04-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-04-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-10-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/002536 |
| Data | 2009-04-24 |
| (87) | Numeris | WO 2009/131702 |
| Data | 2009-10-29 |
| (30) | Numeris | Data | Šalis |
| 48152 P | 2008-04-25 | US | |
| 48500 P | 2008-04-28 | US |
| (72) |
TENHOOR, Christopher, US
MURUGANANDAM, Arumugam, IN
LADNER, Robert, Charles, US
WOOD, Clive, US
BITONTI, Alan, J., US
STATTEL, James, US
MCDONNELL, Kevin, US
LIU, Liming, US
DUMONT, Jennifer, US
SATO, Aaron, US
|
| (73) |
Dyax Corp.,
55 Network Drive, Burlington, MA 01803,
US
Biogen Hemophilia Inc., 9 Fourth Avenue, Waltham, MA 02451, US |
| (54) | ANTIBODIES AGAINST FCRN AND USE THEREOF |
| ANTIBODIES AGAINST FCRN AND USE THEREOF |